How We Verify Dallas-Fort Worth Semaglutide Clinics: Transparent Methodology

Why Verification Matters

Semaglutide is a prescription medication. In the hands of a licensed, supervised clinical practice, it is one of the most effective obesity treatments documented in modern medicine — clinical trials show 15-17% body weight reduction over 68 weeks [1]. In the hands of an unlicensed provider, a clinic using improperly compounded medication, or a practice that abandons patients after the initial consultation, it can cause serious harm.

The Dallas-Fort Worth weight-loss clinic market expanded rapidly following the FDA approval of Wegovy in 2021 and the subsequent shortage that made compounded semaglutide legally available from compounding pharmacies. That growth created a spectrum of quality. At one end, board-certified internal medicine physicians with complete lab panels, weekly monitoring, and transparent pricing. At the other end, pop-up med spas that prescribe semaglutide online, ship medication without a clinical encounter, and publish no information about who prescribed it or from where the medication was sourced.

Most patients searching for semaglutide clinics in DFW have no efficient way to distinguish between these extremes. They rely on Google reviews (which can be gamed), clinic websites (which are written to sell), and word of mouth (which is hit-or-miss). None of those sources systematically verify the things that actually matter: Is this provider licensed? Is the medication legitimately sourced? What happens if you have a side effect?

SemaVerified was built to answer those questions. We do not accept payment from clinics, do not sell advertising, and do not receive referral fees for sending patients anywhere. Our income model and editorial policy are published separately. This page documents exactly what we check, what we do not check, how we score clinics, and how often we update our data. If you find an error or have information that contradicts our findings, the contact form on our editorial policy page reaches our research team directly.

The stakes here are real. Semaglutide is a YMYL (Your Money, Your Life) category search topic. We hold ourselves to the same standard we hold the clinics we evaluate: document your sources, be explicit about your limitations, and update your information when it changes.

Our 5-Step Verification Process

Every clinic in our DFW dataset passes through all five steps before any information is published. Clinics that cannot be verified on a given step are flagged accordingly in our clinic comparison table rather than silently omitted or assumed compliant. Here is what each step involves.

Step 1: Texas Medical Board License Verification

Every semaglutide prescription in Texas must be written by a licensed physician (MD or DO), nurse practitioner (NP), or physician assistant (PA) acting within a valid prescriptive authority agreement. Our first step confirms that the prescribing provider or medical director of each clinic holds an active, unrestricted license with the Texas Medical Board (TMB) or the Texas Board of Nursing (for NPs) [2].

We run three checks for each clinic. First, we search the Texas Medical Board license verification database (tmb.state.tx.us) using the provider name published on the clinic's website, booking platform, or prescription pad. We confirm the license status (Active, Expired, Suspended, Surrendered), any disciplinary actions in the last 10 years, and the license expiration date [2].

Second, for clinics that do not publish a physician name, we query the NPI Registry (nppes.cms.hhs.gov) using the clinic's business name, address, or phone number. The NPI Registry is the federal database of all licensed healthcare providers and organizations. Every legitimate clinic prescribing controlled or regulated medications will have an NPI. A clinic with no discoverable NPI is flagged as "unverified prescriber" in our dataset [3].

Third, we cross-reference any disciplinary history. The TMB publishes a searchable list of all disciplinary orders, formal complaints, and license restrictions. A physician with an active disciplinary order related to prescribing practices, controlled substance misuse, or patient safety receives a specific notation in our dataset regardless of their current license status [2].

Of the 40 DFW clinics in our March 2026 dataset, 38 had a verifiable licensed prescriber on record. Two clinics listed no physician name on their website, published no NPI-searchable information, and did not respond to our direct inquiry requesting prescriber credentials. Those clinics are listed with a "prescriber unverified" flag. We do not remove clinics from our dataset for failing a step — we disclose the gap.

Step 2: Pricing Transparency Assessment

The single most common complaint we hear from DFW semaglutide patients is unexpected costs. A patient signs up for a "$299/month semaglutide program" and receives a bill that includes a $150 initial consultation, $100 in baseline labs, $25/month for B-12 injections, and $75 every three months for follow-up visits — a true first-year cost substantially above what was advertised.

Our pricing transparency assessment evaluates four elements for each clinic [4]:

1. Is the base medication price published? We check the clinic's website, Google Business Profile, and any published menus of services. A clinic that publishes its monthly semaglutide cost earns the first transparency point. A clinic that requires a consultation or inquiry to learn the price does not.

2. Is the initial consultation fee disclosed? Sixty percent of DFW clinics charge an initial consultation fee of $100 or more. We verify whether this fee is disclosed upfront on the website or buried in fine print (or not disclosed until the patient calls or arrives in-office).

3. Are lab costs disclosed? A responsible semaglutide clinic orders baseline labs before prescribing — typically a metabolic panel, thyroid panel, and HbA1c for patients with diabetes risk. We check whether the clinic discloses whether labs are included in the program price or billed separately, and at what cost.

4. Is all-inclusive pricing available? We define "transparent" pricing as a clinic that publishes a complete 12-month cost estimate including medication, consultation, labs, and monitoring visits. Of our 40 DFW clinics surveyed in March 2026, only 8 met this standard [4].

This step is conducted via website review and direct phone inquiry. For direct calls, we use a standardized script asking for the total cost of a 6-month program including all fees. We do not record calls or misrepresent our identity — we identify ourselves as consumer researchers or simply ask the questions a patient would ask.

Step 3: Medication Sourcing Verification

Not all semaglutide is the same. Branded Wegovy and Ozempic are manufactured by Novo Nordisk under FDA-supervised quality control. Compounded semaglutide is produced by compounding pharmacies, and quality varies significantly between those pharmacies. A 2024 FDA investigation found that 20% of tested compounded semaglutide samples contained less active ingredient than labeled, and some contained semaglutide salt forms (semaglutide sodium) rather than the base compound used in Wegovy [5].

Our medication sourcing step asks two questions: What type of semaglutide does this clinic prescribe (branded vs compounded)? And if compounded, what pharmacy produces it?

For branded prescriptions (Wegovy/Ozempic), verification is straightforward — the medication is manufactured by Novo Nordisk and dispensed through licensed retail pharmacies. We confirm the clinic prescribes the branded product and note whether they assist with insurance prior authorization or manufacturer savings programs.

For compounded semaglutide, we research the compounding pharmacy. Our two-step check: (1) Is the pharmacy registered as a 503B outsourcing facility with the FDA? 503B facilities are subject to current Good Manufacturing Practice (cGMP) standards, regular FDA inspections, and batch testing requirements. 503A compounding pharmacies (which serve individual patient prescriptions) have lighter oversight [6]. (2) Has the pharmacy received FDA warning letters, Form 483 observations, or voluntary recalls? We search the FDA's database of warning letters and inspection classifications. Well-regarded DFW-area sourcing pharmacies include Empower Pharmacy (Houston, 503B registered) and Olympia Compounding (registered 503B) — clinics using these pharmacies receive a "verified sourcing" notation. Clinics that decline to disclose their compounding pharmacy are flagged as "sourcing undisclosed."

Of our 40 DFW clinics, 31 disclosed their medication type. Twenty-eight prescribe compounded semaglutide, 3 prescribe branded Wegovy or Ozempic, and 9 declined to disclose or provided unclear answers about medication source [4].

Step 4: Patient Monitoring Protocol Review

Semaglutide is not a medication patients self-manage in isolation. FDA prescribing guidelines for Wegovy specify that providers should monitor patients for gastrointestinal side effects, heart rate changes, and renal function, particularly in the dose titration phase (months 1-5). Clinical best practice includes at minimum monthly check-ins during titration, quarterly monitoring during maintenance, and a baseline lab panel before starting [1].

Our monitoring protocol review evaluates three factors for each clinic:

Monitoring frequency. We categorize clinics as offering weekly, monthly, or on-demand monitoring. "Weekly" means structured check-ins at least every two weeks during the first 60 days. "Monthly" means at least one provider contact per month during titration. "On-demand" means the clinic provides medication but does not proactively schedule follow-up. Of our 40 DFW clinics, 4 offer weekly monitoring (Vital Wellness Texas, Vital Wellness Frisco, Q Day Walk-In Clinic, and The Aesthetics Society), 33 offer monthly monitoring, and 3 are on-demand or undisclosed [4].

Lab panel requirements. We verify whether the clinic requires any lab work before prescribing semaglutide. Best-practice labs before starting GLP-1 therapy include a complete metabolic panel (CMP), thyroid panel (TSH), fasting glucose or HbA1c, and lipid panel. We ask directly or look for published protocols. Clinics that prescribe without baseline labs receive a flag. Of 40 DFW clinics, 26 confirmed lab requirements before prescribing [4].

Provider credentials for monitoring visits. Monitoring visits have different safety implications depending on who conducts them. A visit with an MD or DO is a different clinical encounter than a phone check-in handled by a medical assistant. We note whether monitoring is conducted by licensed providers (MD, DO, NP, PA) or by support staff, where this information is available.

Step 5: Online Reputation Analysis

Reputation data is the most accessible and the least reliable of our five inputs. Google reviews can be purchased, BBB ratings reflect complaint resolution (not care quality), and Yelp has documented problems with review manipulation. We use reputation data to surface serious concerns — patterns of unresolved complaints, sudden rating drops, recurring themes about billing or safety — but we do not weight it heavily in our composite score, and we flag our sourcing limitations explicitly.

Our reputation review covers four sources [7][8]:

Google Business Profile. We record the overall star rating, total review count, and the content of the most recent 10-20 reviews with the lowest ratings. We look for patterns rather than individual outliers. A single 1-star review complaining about wait times is noise. Ten reviews in six months all describing unexpected billing charges is signal.

Better Business Bureau (BBB). We check the clinic's BBB profile (if it exists) for formal complaints, complaint resolution records, and BBB accreditation status. A clinic with multiple unresolved billing complaints at the BBB receives a specific notation in our dataset regardless of its Google rating [7].

Texas Medical Board complaint history. As noted in Step 1, the TMB publishes all formal complaints against licensed physicians. We cross-reference complaint history specifically related to the semaglutide clinic or the prescribing physician with any open or resolved TMB actions [2].

Direct patient feedback. We monitor the SemaVerified contact form and community feedback submitted through our site. Reader-submitted concerns are reviewed by our research team. Where they identify a potential factual issue (e.g., "this clinic changed ownership and the physician listed is no longer there"), we follow up with a direct verification attempt before publishing a correction.

Scoring Methodology

Each clinic receives a composite verification score based on performance across the five steps. The score is a transparency and safety indicator, not a clinical quality rating or a recommendation. A high score means we could verify the things we set out to verify. A low score means we could not — which is itself meaningful information.

Step Weights and Point Values

Maximum composite score: 100 points. Weighting reflects our editorial judgment about which factors are most consequential for patient safety. Scoring is conducted by the SemaVerified research team and reviewed quarterly.

Score Tiers

We group composite scores into four descriptive tiers to make them easy to interpret at a glance:

80–100: Fully Verified. The clinic passed all five steps with no significant gaps. Licensed prescriber confirmed, pricing published and complete, medication sourcing identified and reputable, monitoring protocol in place, and no substantive complaint patterns. As of March 2026, 7 of 40 DFW clinics in our dataset score in this tier.

60–79: Mostly Verified. The clinic passed most steps but has one or two incomplete elements — typically pricing transparency gaps or undisclosed compounding pharmacy information. These clinics are legitimate practices with verifiable providers but some information is missing or unclear. Twenty-two of 40 DFW clinics score here.

40–59: Partially Verified. The clinic has verifiable licensing but failed two or more transparency or sourcing steps. Patients should ask specific questions before committing to treatment. Eight of 40 DFW clinics score in this tier.

Below 40: Insufficient Data. We could not verify one or more core elements, including prescriber licensing or medication source. This does not mean the clinic is unsafe — it means we do not have sufficient data to assess it. Clinics in this tier are listed with specific flags identifying what we could not confirm. Three of 40 DFW clinics fall here, primarily because they declined to respond to our verification inquiries.

What Scores Do Not Mean

A high verification score does not mean a clinic will produce good clinical outcomes for you specifically. Semaglutide response varies by patient, and our scoring system measures transparency and verifiability, not clinical efficacy. A clinic with a score of 95 may not be the right fit for a particular patient's medical needs. A clinic with a score of 55 may provide excellent care to their specific patient population — they simply publish less information publicly. Use our scores as a starting point for your own due diligence, not as a final verdict.

What We Do NOT Verify

Being explicit about our limitations is as important as describing our process. Here is what falls outside our verification scope, and why.

Clinical outcomes. We do not track or verify how much weight patients lose at specific clinics, what percentage achieve maintenance at 12 months, or how their side effect profiles compare. Reliable outcomes data requires a clinical registry, patient consent, and longitudinal follow-up — none of which we operate. Clinics that advertise specific outcome statistics ("15% average weight loss in 12 weeks") are making claims we cannot independently confirm. Treat those figures with appropriate skepticism unless they cite a published clinical study.

Patient satisfaction. We do not conduct patient satisfaction surveys. Our reputation step reviews publicly available feedback, but this is a different thing from structured satisfaction research. Two patients at the same clinic can have entirely different experiences, and neither experience invalidates the other.

Insurance acceptance. Insurance coverage for semaglutide is determined by your specific plan, not by the clinic. We note in our dataset which clinics assist with prior authorization paperwork, but we do not verify real-time insurance participation. Call your insurance carrier directly and ask whether a specific clinic is in-network before scheduling.

Same-day accuracy. Our data is verified on a rolling schedule (see Update Process below). Between update cycles, pricing, staffing, or practices at a clinic may change. We publish verification dates on every data point. If you are reading a clinic entry that was last verified more than 90 days ago, confirm the key details directly with the clinic before acting on it.

Data Sources

Our five-step verification process draws on the following authoritative sources. All are publicly accessible.

Texas Medical Board (TMB) License Verification Database. Available at tmb.state.tx.us. The primary source for confirming physician license status, license type (MD, DO), expiration date, and any disciplinary actions. Updated in real-time by the TMB as actions are taken [2].

National Provider Identifier (NPI) Registry. Available at nppes.cms.hhs.gov. Federal database of all licensed healthcare providers and organizations. We use it to identify prescribing providers at clinics that do not publish physician names, and to confirm that clinics have active NPI registrations as required for prescription billing [3].

Texas State Board of Pharmacy (TSBP). Available at pharmacy.texas.gov. Used to verify compounding pharmacy licenses in Texas and to check for any disciplinary actions against pharmacies supplying DFW clinics. Texas 503A and 503B compounders must register with TSBP in addition to FDA requirements [6].

FDA Drug Shortage Database and Warning Letter Database. Available at accessdata.fda.gov. We use the shortage database to confirm current semaglutide shortage status (which determines whether compounding is legally permitted) and the warning letter database to flag compounding pharmacies that have received FDA enforcement actions [5][6].

Google Business Profiles. Clinic ratings, review counts, and recent low-rating reviews. Used in Step 5 for complaint pattern detection. We do not treat Google ratings as a standalone quality signal [7].

Better Business Bureau (BBB). Formal complaint records and resolution history for clinics with BBB profiles. Used alongside Google data in Step 5 to identify unresolved billing or safety disputes [8].

Direct clinic inquiry. For pricing, monitoring protocols, and medication sourcing, we conduct direct phone or email inquiry using a standardized script. All inquiries are made transparently — we do not misrepresent our purpose [4].

Update Process

The semaglutide clinic market in DFW changes frequently. Prices change. Clinics open and close. Physicians leave practices. Compounding pharmacy regulatory status shifts. Our update schedule reflects those realities.

Monthly pricing reverification. Every month, we re-check published pricing for all 40 DFW clinics in our dataset by reviewing clinic websites and calling 5-10 clinics with the largest discrepancy between our last-recorded price and any updated published price. If a clinic has changed its pricing, our dataset and any pages referencing that clinic are updated within 5 business days of confirmation. The "last verified" date on every clinic entry reflects the most recent pricing confirmation.

Quarterly full review. Every three months, we re-run all five verification steps for every clinic in our dataset. This includes re-checking TMB license status (licenses can be suspended or expire between cycles), repeating the medication sourcing inquiry, and reviewing any new BBB complaints or TMB actions filed since the previous review. The dataset is considered "fully current" only after a full quarterly review is complete. The last full review date is published on this page and on our editorial policy page.

Triggered updates. We update clinic entries outside the regular cycle when we receive reader-submitted information that suggests a material change (ownership change, new disciplinary action, pricing shift), when an FDA or TMB action is published affecting a provider in our dataset, or when a clinic directly contacts us to correct an error. Corrections are noted with a "corrected" flag and the date of correction.

Clinic review requests. Any clinic in the DFW market can request a verification review by contacting our research team through the form on our editorial policy page. We do not charge for review. We do not guarantee placement or a specific score. Clinics that provide documentation supporting a higher verification score (e.g., supplying their compounding pharmacy's FDA registration number after being listed as "sourcing undisclosed") will have their entry updated accordingly, with a note indicating the information was provided by the clinic and the date it was received.

Verification FAQ